Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case study: the link between hypertension and diabetes.

George L Bakris, Edgar R Gonzalez

    Journal of Managed Care Pharmacy : JMCP
    |July 4, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects.

    Nature reviews. Nephrology·2021
    Same author

    Longitudinal Blood Pressure Patterns and Chronic Kidney Disease Progression: An Evolving Paradigm.

    Hypertension (Dallas, Tex. : 1979)·2021
    Same author

    Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial.

    Diabetes, obesity & metabolism·2021
    Same author

    Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.

    The New England journal of medicine·2021
    Same author

    Intersection Between Chronic Kidney Disease and Cardiovascular Disease.

    Current cardiology reports·2021
    Same author

    Approach to Resistant Hypertension from Cardiology and Nephrology Standpoints: Tailoring Therapy.

    Cardiology clinics·2021

    Diabetics with hypertension often face complications. Newer beta-blockers like nebivolol improve renal function without negatively impacting glucose or lipid levels, unlike older agents.

    Area of Science:

    • Cardiology
    • Endocrinology
    • Nephrology

    Background:

    • Hypertension is a common complication in diabetes mellitus.
    • Hypertension significantly increases the risk of cardiovascular and microvascular damage in diabetic patients.

    Observation:

    • A case study reviewed a patient with poorly controlled hypertension and diabetes.
    • The patient presented with metabolic syndrome, diabetes, microalbuminuria, and peripheral arterial disease.

    Findings:

    • Despite multiple medications, the patient's hypertension remained poorly controlled.
    • Polypharmacy complicated glycemic control.
    • Newer vasodilatory beta-blockers, such as nebivolol, offer advantages over older agents.
    • Nebivolol stimulates nitric oxide release, improving renal function and not affecting glucose or lipid parameters.

    Related Experiment Videos

    Implications:

    • Careful evaluation of antihypertensive treatment is crucial for diabetic patients with metabolic syndrome.
    • Nebivolol represents a potentially safer beta-blocker option for managing hypertension in complex diabetic patients.
    • Optimizing treatment can mitigate cardiovascular and microvascular risks in this population.